OtherCardiovascular
A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion
Peipei Wang, Heather Fraser, Steven G. Lloyd, Jeffrey J. McVeigh, Luiz Belardinelli and John C. Chatham
Journal of Pharmacology and Experimental Therapeutics January 3, 2007, DOI: https://doi.org/10.1124/jpet.106.115519